Ann: Investor Newsletter, page-4

I am sure they advised what the fee per use was at some stage, however I cant find it. This is a good revenue stream also considering there is a recurring license fee per site, but the more it is used the more revenue is generated.

That is why I am interested to see the number of screenings undertaken using the software. It clearly a volume proposition for the company. literally every click = $$$

Moving from 1-3% in the first 'full year' of a full time targeted sales team, how soon before we get to 10% of all women in the US screened.

I anticipate that next year we will be paying the bills from sales, and the rest will go to profit & R&D. Then I believe we will see the sale price really take off.

If we can achieve a SP of $0.80 - $1.00 by eoCY17, and exceed the 200% ARR target I would expect considerable interest in CY18.